Projects

This section presents pharmaceutical projects that are announced from time-to-time around the world.

Teva to set up API facility in India

Teva is planning to set up an Active Pharmaceutical Ingredient in the country. The project is aimed to be achieved in the next two years.

PTR to build stem cell manufacturing plant in Malayasia

Pahang Technology Resources is teaming up with BCRO Stem Cell Xenotransplantation to jointly build a stem cell manufacturing plant in Malayasia.

Genentech sets up manufacturing plant in Singapore

Genentech is setting up a microbial- based biologics manufacturing plant in Singapore with an investment of approximately US$ 140 million by 2010. It is intended to manufacture LUCENTIS® for curing wet age-related macular degeneration.

Aptuit Laurus's new manufacturing facility in India

Aptuit, Inc. and Laurus Labs Limited have formed a joint venture to offer manufacturing facilities in Vishakhapatnam. The initial phase of the manufacturing plant is expected to complete by early 2008.

New R&D Center in Madhya Pradesh, India

The Government of Madhya Pradesh proposes to establish an integrated R&D center in the State. The center will offer specialty services in drug discovery.

Janssen-Cilag and Johnson & Johnson to open new facility in Mumbai

Janssen-Cilag and Johnson & Johnson Pharmaceutical Research & Development (J&JPRD) broke ground for a future pharmaceutical research building after opening the extended and renovated Analytical & Pharmaceutical Development Center (APDC) in Mumbai.

Klöckner Pentaplast to build manufacturing plant in India

The Klöckner Pentaplast Group (kp) a leading producer and supplier of films for pharmaceutical, medical device, and general-purpose thermoform packaging announced its plans to build a manufacturing plant in India in Aurangabad.

Dragon to build new nanotechnology packaging plant

Dragon International Group Corp plans to build a new manufacturing facility which will be utilised to make new packaging products developed through the use of nanotechnologies.

Zydus and Mayne builds new plant to manufacture oncology products in India

Zydus Cadila and Mayne Pharma to set up a 50:50 joint venture company to manufacture generic injectable, cytotoxic (anti-cancer) medicines and active pharmaceutical ingredients (API) for global markets.

Dishman Pharma manufacturing facility in Shanghai

Dishman Pharmaceuticals and Chemicals Ltd is setting up a new greenfield manufacturing facility in Shanghai Chemical Industry Park at a cost of Rs 45 crore ($10 million). The project is expected to go on stream by the end of 2007.

Novartis’s new strategic biomedical R&D center in Shanghai

Novartis announced plans to build an integrated biomedical Research & Development center in Shanghai's Zhangjiang Hi-Tech Park. Initial investment of USD 100 million to create Shanghai site, set to begin operations in May 2007.

GSK’s New R&D Plant in Singapore

GlaxoSmithKline (GSK) is investing US$ 115 million in a new R&D pilot plant at its Global Manufacturing Supply (GMS) site in Jurong, Singapore.

Lonza Group and Bio*One’s Custom Biopharmaceuticals Plant, Singapore

In a joint venture, Lonza Group, a Swiss chemical and biotechnology company, and Singapore’s Bio*One Capital, biomedical sciences investment management company, are developing mammalian cell culture plant in Singapore. The project is scheduled for completion by the end of 2009 with an estimated investment of US$ 250 million.